Gastric Enterovirus Infection: A Possible Causative Etiology of Gastroparesis
Autor: | Nancy G. Klimas, Jodie A. Barkin, Irma R. Rey, Jamie S. Barkin, Frank Czul, Baharak Moshiree |
---|---|
Rok vydání: | 2016 |
Předmět: |
Adult
Male medicine.medical_specialty Gastroparesis Physiology Biopsy medicine.disease_cause Antiviral Agents Gastroenterology Postural Orthostatic Tachycardia Syndrome Young Adult 03 medical and health sciences 0302 clinical medicine Inosine Pranobex Internal medicine Ribavirin Enterovirus Infections Humans Immunologic Factors Medicine Young adult 2-Aminopurine Aged medicine.diagnostic_test business.industry Stomach Famciclovir Immunoglobulins Intravenous Middle Aged Hepatology medicine.disease Surgery medicine.anatomical_structure Gastritis 030220 oncology & carcinogenesis Gastroesophageal Reflux Etiology Enterovirus Female 030211 gastroenterology & hepatology medicine.symptom business |
Zdroj: | Digestive Diseases and Sciences. 61:2344-2350 |
ISSN: | 1573-2568 0163-2116 |
Popis: | Gastroparesis (GP) is a disabling chronic gastroenterologic disorder with high morbidity that severely impacts patients’ quality of life. GP can present acutely after a viral-like gastrointestinal illness resulting in speculation that in some patients, neurologic damage caused by the infection might underlie the pathogenesis of idiopathic gastroparesis (IGP). The aim of this study is to document case reports of Enterovirus (EV) infection as a possible cause of IGP. Eleven patients referred with a diagnosis of GP underwent workup to exclude known causes of GP. Those with a history of flu-like symptoms or gastroenteritis prior to onset of GP symptoms had gastric biopsies taken during upper endoscopy to assess for the presence of gastric mucosal EV infection. Data on presenting symptoms, extra-intestinal symptoms and conditions, prior nutritional support requirements, upper endoscopy findings, and response to therapy were cataloged. Eleven patients were diagnosed as IGP. Nine had active EV infection on gastric biopsies and were included (7/9 female, mean age 43 years). Eight out of nine received EV treatment with antivirals and/or immune therapies, with a wide degree of variability in treatment regimens. Four out of eight who received EV treatment had symptomatic improvement. One patient had stable symptoms. Three patients are currently undergoing therapy. Gastric EV infection was frequently detected (82 %) in patients undergoing investigation for IGP. Antiviral and/or immune therapies against EV seem to be favorable, as most of our patients had resolution of their GP symptoms after treatment. This is the first study to identify EV as a possible infectious etiology of IGP. |
Databáze: | OpenAIRE |
Externí odkaz: |